Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Prof Anne Goriely and Prof Alison Simmons, who have both been awarded Wellcome Trust Investigator Awards.

Anne Goriely is an Associate Professor of Human Genetics at the Radcliffe Department of Medicine. Her award will support a research programme focusing on a process called selfish selection, promoting clonal expansion of pathogenic de novo mutations in human testes/male germline. De novo mutations are widely thought to occur randomly. However, the group has challenged this assumption by showing that so-called selfish mutations are able to hijack the cellular control of male germline stem cells in which they arise, leading to their preferential transmission to the next generation. The Goriely group will use state-of-the-art technology to assess the significance of selfish selection for human disease and genome evolution.

Alison Simmons is a Professor of Gastroenterology at the Nuffield Department of Medicine and MRC Human Immunology Unit, and was recently elected a Fellow of the Academy of Medical Sciences. The Simmons lab works on Inflammatory Bowel Disease (IBD), a debilitating condition that affects more than 300,000 people in the UK. In IBD, the protective barrier that separates gut luminal microbes from the mucosal immune system is disrupted, leading to inflammation. Recently, the group used single cell technologies to chart the diverse cell types making up the gut mucosal barrier, uncovering new cell types and key pathways of barrier defence. The new Wellcome Investigator Award will define the relationships and signalling between these myriad cell types of the barrier and explore how these can be harnessed to promote intestinal health.

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.